Pro Medicus (OTCMKTS:PMCUF) Stock Price Down 5% – What’s Next?

Pro Medicus Limited (OTCMKTS:PMCUF) dropped 5% during trading on Friday. The stock traded as low as $108.86 and last traded at $108.86. Approximately 300 shares traded hands during mid-day trading, a decline of 49% from the average daily volume of 583 shares. The stock had previously closed at $114.56.

Analyst Ratings Changes

Separately, Jefferies Financial Group downgraded shares of Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $155.00.

Pro Medicus Stock Performance

The company has a 50 day moving average price of $121.59 and a 200 day moving average price of $111.50.

About Pro Medicus

Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its primary product is the Visage enterprise imaging platform, which supports the storage, management, viewing and distribution of diagnostic images such as X-rays, CT scans and magnetic resonance images.

The company’s software is designed to help hospitals, radiology practices and other healthcare providers manage imaging workflows and enable clinicians to access diagnostic information across locations.